0EL:F:F-YIDU TECH INC. DL -00002 (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.328

Change

0.00 (0.00)%

Market Cap

USD 0.36B

Volume

42.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Yidu Tech Inc., an investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People's Republic of China, Brunei, Singapore, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, and Health Management Platform and Solutions segments. The Big Data Platform and Solutions segment offers data intelligence platforms and data analytics-driven solutions; AI solutions for a range of medical treatment, education, research, and hospital management scenarios; all disease data platforms; and operates a data center under the YiduEywa name for hospitals and medical institutions. The Life Sciences Solutions segment offers analytics-driven clinical development, real-world study and evidence, and digital commercialization solutions to pharmaceutical, biotech, medical device, and other companies. The Health Management Platform and Solutions segment provides health management platform application and solution services; operation of YiduCore, an AI medical brain, that extracts, structures, and standardizes the raw and dispersed medical data and transforms it into deep medical insights and practical solutions; distribution of insurance companies' products; and sale of pharmaceutical products and related hardware and other services, as well as offers personalized digital therapies and out-of-hospital care services. It also engages in the sale of medical devices; provision of insurance brokerage and technology services; and medical and computer technology research and development, and investment holding activities. The company serves healthcare industry participants, including hospitals, research institutions, insurance companies, doctors, patients, and regulators and policy makers, as well as pharmaceutical, biotech, and medical device companies. Yidu Tech Inc. was incorporated in 2014 and is headquartered in Beijing, China. Address: Building 9, Jiankang Zhigu Building, Beijing, China

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

N/A

USD 35.91B
4YC:F M3 INC.

N/A

USD 6.19B
2HE:F Healthequity Inc

N/A

USD 6.16B
6HL0:F R1 RCM Inc

N/A

USD 5.36B
9EH:F Evolent Health Inc

N/A

USD 3.16B
1KJ:F 10X GENOMICS DL -00001

N/A

USD 2.31B
6JM:F JMDC INC.

N/A

USD 1.93B
OC9:F Omnicell Inc

N/A

USD 1.76B
4LL:F Teladoc Inc

N/A

USD 1.25B
19P:F Phreesia Inc

N/A

USD 1.22B

ETFs Containing 0EL:F

HKDU:SW UBS(Lux)Fund Solutions .. 4.48 % 0.00 %

N/A

N/A
FLHK Franklin FTSE Hong Kong E.. 4.18 % 0.09 %

N/A

USD 0.01B
IQLT iShares MSCI Intl Quality.. 0.21 % 0.30 %

N/A

USD 8.36B
IPAC iShares Core MSCI Pacific.. 0.20 % 0.10 %

N/A

USD 2.11B
EFA iShares MSCI EAFE ETF 0.00 % 0.31 %

N/A

N/A
EPP iShares MSCI Pacific ex J.. 0.00 % 0.48 %

N/A

N/A
EWH iShares MSCI Hong Kong ET.. 0.00 % 0.48 %

N/A

N/A
ZHOK 0.00 % 0.14 %

N/A

N/A
TILV:CA TD Q International Low Vo.. 0.00 % 0.00 %

N/A

CAD 0.08B
ILV-F:CA 0.00 % 0.00 %

N/A

N/A
RWW:CA 0.00 % 0.66 %

N/A

N/A
3012:HK Amundi Hang Seng HK 35 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -42.46% 29% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -42.46% 29% F 11% F
Trailing 12 Months  
Capital Gain -26.46% 50% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -26.46% 47% F 21% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -15.41% 32% F 15% F
Dividend Return -15.41% 30% F 14% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.39% 71% C- 59% D-
Risk Adjusted Return -75.57% 24% F 12% F
Market Capitalization 0.36B 67% D+ 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.